Compare UNH & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UNH | ABT |
|---|---|---|
| Founded | 1977 | 1888 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 318.5B | 189.6B |
| IPO Year | 2010 | 2006 |
| Metric | UNH | ABT |
|---|---|---|
| Price | $288.77 | $113.80 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 25 | 18 |
| Target Price | ★ $387.79 | $141.00 |
| AVG Volume (30 Days) | 7.4M | ★ 8.2M |
| Earning Date | 04-29-2026 | 04-23-2026 |
| Dividend Yield | ★ 3.00% | 2.21% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 13.23 | 3.72 |
| Revenue | ★ $447,567,000,000.00 | $44,328,000,000.00 |
| Revenue This Year | N/A | $8.92 |
| Revenue Next Year | $3.31 | $7.39 |
| P/E Ratio | ★ $22.27 | $30.78 |
| Revenue Growth | ★ 11.81 | 5.67 |
| 52 Week Low | $234.60 | $105.27 |
| 52 Week High | $606.36 | $139.15 |
| Indicator | UNH | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 46.64 | 47.90 |
| Support Level | $269.68 | $111.18 |
| Resistance Level | $294.23 | $113.76 |
| Average True Range (ATR) | 7.96 | 1.89 |
| MACD | 2.81 | 0.64 |
| Stochastic Oscillator | 77.41 | 43.66 |
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.